Amgen Announces Award for Science Teaching Excellence in California
A Statewide Call for Nominations
Nominations Deadline: February 29, 2004
THOUSAND OAKS, Calif., Jan. 5 -- Amgen Inc. (Nasdaq: AMGN),
the world's largest biotechnology company, today announced it has begun
accepting nominations for the 2004 Amgen Award for Science Teaching Excellence
in California, the company's statewide recognition program for science
education. Five K-12 educators who work in either public or private schools
in California will each receive an unrestricted $10,000 award from Amgen, and
statewide recognition, at a special award ceremony in Los Angeles in May.
Amgen developed its teaching award in Ventura County 12 years ago. More
recently, the company broadened the award program to include teachers
throughout the state, and focused solely on those who teach science. Amgen
also conducts similar programs in Colorado; Louisville, Kentucky; Boston and
Cambridge, Massachusetts; Puerto Rico; Rhode Island; and Seattle, Washington.
Anyone can nominate an educator who teaches science. The nomination letter
should include: the full name of the teacher; the name and address of the
school; the name of the school district; the school's phone number; the grade
level taught by the science teacher; the nominator's relationship to the
science teacher; the nominator's phone number; and a description of why the
science teacher deserves the award, including the teacher's attributes in the
areas of creativity, effectiveness, best practice development, and
instructional and motivational ability.
Letters should be sent to: Amgen Award for Science Teaching Excellence,
Attn: AnNette Chavez, Amgen Inc., One Amgen Center Drive, Mailstop 38-3-B,
Thousand Oaks, CA 91320-1799. Nominations can also be submitted
electronically, at www.Amgen.com/ScienceTeacherAward/. Nominations for the
award will be accepted immediately, through February 29, 2004.
Amgen is a leading global biotechnology company that discovers, develops,
manufactures and markets important human therapeutics based on advances in
cellular and molecular biology.
CONTACT: Amgen, Thousand Oaks
Mary Klem: (805) 447-6979
Amgen, Corporate Communications